Xencor, Inc.
TARGETED HETERODIMERIC Fc FUSION PROTEINS CONTAINING IL-15 IL-15alpha AND ANTIGEN BINDING DOMAINS
Last updated:
Abstract:
The present invention is directed to a novel targeted heterodimeric Fc fusion proteins comprising an IL-15/IL-15R.alpha. Fc fusion protein and an antigen binding domain Fc fusion proteins. In some instances, the antigen binding domain binds to CD8, NKG2A, or NKG2D.
Status:
Application
Type:
Utility
Filling date:
2 Jul 2021
Issue date:
10 Mar 2022